Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology

Shares in Swedish drug-delivery company Nanexa OMXSTO:NANEXA more than doubled their value in early Friday trading after it signed a global licensing deal with Novo Nordisk OMXCOP:NOVO_B worth up to about €1.17 billion ($1.33 billion).The agreement, announced after the market closed on Thursday, co…